Liver Cancer - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Liver Cancer > What Your Doctor is Reading About Liver Cancer > Review Articles

Review Articles

1. New aspects of diagnosis and therapy of hepatocellular carcinoma.

Author: Bruix J; Hessheimer AJ; Forner A; Boix L; Vilana R; Llovet JM;
Institution: BCLC Group, Liver Unit, IDIBAPS, Digestive Disease Institute, Hospital Clinic, University of Barcelona, Catalonia, Spain. bruix@ub.edu
Journal: Oncogene. 2006 Jun 26;25(27):3848-56.
Abstract URL: Click here to view abstract

2. New therapies for hepatocellular carcinoma.

Author: Avila MA; Berasain C; Sangro B; Prieto J;
Institution: Division of Hepatology and Gene Therapy, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Journal: Oncogene. 2006 Jun 26;25(27):3866-84.
Abstract URL: Click here to view abstract

3. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation.

Author: Luk JM; Wang X; Liu P; Wong KF; Chan KL; Tong Y; Hui CK; Lau GK; Fan ST;
Institution: Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong. jmluk@hku.hk
Journal: Liver Int. 2007 Sep;27(7):879-90.
Abstract URL: Click here to view abstract

4. Hepatocellular carcinoma.

Author: Marrero JA;
Institution: University of Michigan, Ann Arbor, 48109, USA. jmarrero@umich.edu
Journal: Curr Opin Gastroenterol. 2006 May;22(3):248-53.
Abstract URL: Click here to view abstract

5. Selection of patients with hepatocellular carcinoma for liver transplantation.

Author: Sutcliffe R; Maguire D; Portmann B; Rela M; Heaton N;
Institution: Institute of Liver Studies, King's College Hospital, Denmark Hill, London SE5 9RS, UK.
Journal: Br J Surg. 2006 Jan;93(1):11-8.
Abstract URL: Click here to view abstract

6. Radiofrequency ablation of liver tumors: a systematic review.

Author: Sutherland LM; Williams JA; Padbury RT; Gotley DC; Stokes B; Maddern GJ;
Institution: Australian Safety and Efficacy Register of New Interventional Procedures-Surgical, Royal Australasian College of Surgeons, Stepney.
Journal: Arch Surg. 2006 Feb;141(2):181-90.
Abstract URL: Click here to view abstract

7. Hepatocellular carcinoma. An overview.

Author: Motola-Kuba D; Zamora-Valdes D; Uribe M; Mendez-Sanchez N;
Institution: Department of Biomedical Research and Liver Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
Journal: Ann Hepatol. 2006 Jan-Mar;5(1):16-24.
Abstract URL: Click here to view abstract

8. Transarterial chemoembolization for hepatocellular carcinoma.

Author: Lau WY; Yu SC; Lai EC; Leung TW;
Institution: Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, HKSAR, China.
Journal: J Am Coll Surg. 2006 Jan;202(1):155-68. Epub 2005 Oct 19.

9. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.

Author: O'Neil BH; Venook AP;
Institution: University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA. bert_oneil@med.unc.edu
Journal: Oncologist. 2007 Dec;12(12):1425-32.
Abstract URL: Click here to view abstract

10. Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents.

Author: Alisi A; Balsano C;
Institution: Laboratorio di Virologia ed Oncologia Molecolare, Fondazione Andrea Cesalpino, University of Rome La Sapienza, Rome, Italy.
Journal: Nutr Rev. 2007 Dec;65(12 Pt 1):550-3.
Abstract URL: Click here to view abstract

11. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.

Author: Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW;
Institution: Dumont-University of California, Los Angeles, Transplant Center, 77-120 CHS, Box 957054, 10833 Le Conte Ave, Los Angeles, CA 90095-7054, USA.
Journal: Arch Surg. 2008 Feb;143(2):182-8; discussion 188.
Abstract URL: Click here to view abstract

12. Liver cirrhosis.

Author: Schuppan D; Afdhal NH;
Institution: Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. dschuppa@bidmc.harvard.edu
Journal: Lancet. 2008 Mar 8;371(9615):838-51.
Abstract URL: Click here to view abstract

13. Microwave ablation of hepatocellular carcinoma.

Author: Liang P; Wang Y;
Institution: Department of Ultrasound, Chinese PLA General Hospital, Beijing, PR China. liangping301@hotmail.com
Journal: Oncology. 2007;72 Suppl 1:124-31. Epub 2007 Dec 13.
Abstract URL: Click here to view abstract

14. Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability.

Author: Lau WY; Lai EC;
Institution: Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, SAR, China. josephlau@cuhk.edu.hk
Journal: Ann Surg Oncol. 2007 Dec;14(12):3301-9. Epub 2007 Sep 22.
Abstract URL: Click here to view abstract

15. Consensus and controversy in the management of hepatocellular carcinoma.

Author: Kim RD; Reed AI; Fujita S; Foley DP; Mekeel KL; Hemming AW;
Institution: Division of Transplantation and Hepatobiliary and Pancreatic Surgery, Department of Surgery, University of Florida School of Medicine, Gainesville, FL 32610-0286, USA.
Journal: J Am Coll Surg. 2007 Jul;205(1):108-23.

16. Treatment of HCC in patients awaiting liver transplantation.

Author: Schwartz M; Roayaie S; Uva P;
Institution: Mount Sinai Medical Center, Surgery/Transplant, New York, NY, USA. myron.schwrtz@mountsinai.org
Journal: Am J Transplant. 2007 Aug;7(8):1875-81. Epub 2007 May 26.
Abstract URL: Click here to view abstract

17. Strategies for the management of hepatocellular carcinoma.

Author: Schwartz M; Roayaie S; Konstadoulakis M;
Institution: Mount Sinai School of Medicine, New York, NY 10029, USA. myron.schwartz@mssm.edu
Journal: Nat Clin Pract Oncol. 2007 Jul;4(7):424-32.
Abstract URL: Click here to view abstract

18. Hepatocellular cancer: a guide for the internist.

Author: Parikh S; Hyman D;
Institution: Department of Medicine, Baylor College of Medicine, Houston, Tex, USA. parikh@bcm.tmc.edu
Journal: Am J Med. 2007 Mar;120(3):194-202.
Abstract URL: Click here to view abstract

19. Multidisciplinary treatment of patients with hepatocellular carcinoma.

Author: Masaki T; Morishita A; Kurokohchi K; Kuriyama S;
Institution: Kagawa Medical University, Third Department of Internal Medicine, 1750-1 Ikenobe Miki-cho, Kita-gun, Kagawa 761-0793, Japan. tmasaki@kms.ac.jp
Journal: Expert Rev Anticancer Ther. 2006 Oct;6(10):1377-84.
Abstract URL: Click here to view abstract

20. Gene therapy of liver cancer.

Author: Hernandez-Alcoceba R; Sangro B; Prieto J;
Institution: Division of Gene Therapy and Hepatology, Edificio CIMA, Av. Pio XII, 55, Pamplona 31008, Spain.
Journal: World J Gastroenterol. 2006 Oct 14;12(38):6085-97.
Abstract URL: Click here to view abstract

21. Early detection and curative treatment of early-stage hepatocellular carcinoma.

Author: Kudo M;
Institution: Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
Journal: Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S144-8.
Abstract URL: Click here to view abstract

22. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

Author: Schwartz M; Roayaie S; Llovet J;
Institution: Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, USA. myron.schwartz@mssm.edu
Journal: J Hepatol. 2005 Oct;43(4):584-9.

23. Emerging drugs for hepatocellular carcinoma.

Author: Roberts LR; Gores GJ;
Institution: Mayo Clinic College of Medicine, Miles and Shirley Fiterman Center for Digestive Diseases, 200 First Street SW, Rochester, MN 55905, USA. Roberts.Lewis@mayo.edu
Journal: Expert Opin Emerg Drugs. 2006 Sep;11(3):469-87.
Abstract URL: Click here to view abstract

24. Liver transplantation for hepatocellular carcinoma: an update.

Author: Botha JF; Langnas AN;
Institution: Department of Surgery, Section of Transplantation, UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE 68198-3285. jbotha@unmc.edu
Journal: J Natl Compr Canc Netw. 2006 Sep;4(8):762-7.
Abstract URL: Click here to view abstract

25. Liver-directed therapies for hepatocellular carcinoma.

Author: Arciero CA; Sigurdson ER;
Institution: Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Journal: J Natl Compr Canc Netw. 2006 Sep;4(8):768-74.
Abstract URL: Click here to view abstract

26. Liver-directed therapies for patients with primary liver cancer and hepatic metastases.

Author: Arciero CA; Sigurdson ER;
Institution: Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Journal: Curr Treat Options Oncol. 2006 Sep;7(5):399-409.
Abstract URL: Click here to view abstract

27. Opportunities for targeted therapies in hepatocellular carcinoma.

Author: Thomas MB; Abbruzzese JL;
Institution: Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. methomas@mdanderson.org
Journal: J Clin Oncol. 2005 Nov 1;23(31):8093-108.
Abstract URL: Click here to view abstract

28. Transarterial chemoembolization in a patient with recurrent hepatocellular carcinoma and portal vein thrombosis: a case report and review of the literature.

Author: Sikander A; Sadashiv S; Ronald S; Milind J;
Institution: Department of Medicine, Roswell Park Cancer Institute and State University of New York at Buffalo, NY 14263, USA. ailawadhi77@yahoo.com
Journal: Am J Clin Oncol. 2005 Dec;28(6):638-9.
Abstract URL: Click here to view abstract

29. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.

Author: Pang R; Poon RT;
Institution: Department of Medicine, Centre for Cancer Research, The University of Hong Kong, Pokfulam, Hong Kong, China.
Journal: Cancer Lett. 2006 Oct 28;242(2):151-67. Epub 2006 Mar 27.
Abstract URL: Click here to view abstract

30. Radiofrequency ablation for malignant liver tumor.

Author: Ng, Kelvin K; Poon, Ronnie T;
Institution: Department of Surgery, Centre for the Study of Liver Disease, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.
Journal: Surg Oncol 2005 Jul;14(1):41-52.
Abstract URL: Click here to view abstract